Abstract:We read with great interest the article by Onuma et al. [1] which evaluated the long-term safety and efficacy of ABSORB bioasorbable everolimus-eluting stent (BVS) scaffold. The investigators of the study have made pioneering contributions to the assessment of bioresorbable scaffolds. It was concluded that sustained safety could be achieved after the implantation of a fully bioresorbable Absorb everolimus-eluting scalffold with a low event rate at 5 years. Besides, the ABSORB Cohort A trial confirmed the feasibility of noninvasive anatomic and functional assessment of the scaffold with the use of multislice computed tomography (MSCT) angiography and MSCT-based fractional flow reserve (FFR) assessment. However, we have several concerns with regard to the study. First, we have to notice that noninvasive FFR analysis was feasible only in 13 patients. The limited size has weakened the reliability of noninvasive FFR performance in assessing functional outcome of ABSORB BVS. Good image quality of all coronary arteries and accurate lumen boundary descriptions are essential for the noninvasive FFR interpretation [2]. Although published reports suggested that CT derived FFR (FFRCT) accuracy was less affected by MSCT image quality than CT stenosis [3], there were four patients (22.2%) who cannot have FFRCT analysis due to severe artifact. Besides, in those with feasible FFRCT, numerous artifacts including calcification, motion, and misregistration may also affect MSCT performance and lead to inaccurate anatomic models for FFRCT computation [4]. Thus, the feasibility and precision of FFRCT need to be further improved. It is not appropriate to use FFRCT alone as a hemodynamic parameter in functional coronary stenosis measurement. Second, a fly in the ointment of the study was the absence of invasive FFR as a reference against noninvasive FFRCT at 5 years. Despite Onuma et al. demonstrated several reasons that they decided to perform repeat MSCT alone instead of invasive imaging, we cannot deny the fact that no published convincing trial exists for FFRCT in the evaluation of interventional treatment [4], although the DISCOVER-FLOW study [5] validated that the FFRCT had a good correlation with an invasive FFR, and the DeFACTO trial [6] demonstrated that the FFRCT plus CT was superior to CT alone as a measure of coronary computed tomography angiography (CCTA) stenosis severity for determination of lesion-specific ischemia. Finally, in the study, angiographic reference standard of the vessel lumen area was derived from MSCT analysis instead of invasive coronary angiography [1]. It is important, however, to note that there is an overestimation of stenosis severity identified by CCTA and even among severe stenosis confirmed by invasive coronary angiography, only a minority cause ischemia [4,6]. Therefore, the possible deviation resulted from the inaccurate reference of MSCT may make the results less convincible.

A Comparison of Dynamic SPECT Coronary Flow Reserve with TIMI Frame Count in the Treatment of Non-Obstructive Epicardial Coronary Patients

Effect of lesion characteristics on diagnostic performance of CT-derived fractional flow reserve: exploring the indications for application based on CT-FFR CHINA trial (Preprint)

A comparative study of optimization algorithm FFR-CT and invasive FFR

Functional Significance of Intermediate Coronary Stenosis in Patients with Single-Vessel Coronary Artery Disease: A Comparison of Dynamic SPECT Coronary Flow Reserve with Intracoronary Pressure-Derived Fractional Flow Reserve (FFR)

Diagnostic Performance of Computational Fluid Dynamics (Cfd)-Based Fractional Flow Reserve (FFR) Derived from Coronary Computed Tomographic Angiography (CCTA) for Assessing Functional Severity of Coronary Lesions

Evaluate the Correlation Between the TIMI Frame Count, IMR, and CFR in Coronary Microvascular Disease

Challenges in Multislice Computed Tomography Based Fractional Flow Reserve to Evaluate Interventional Treatment

Evaluation of Fractional Flow Reserve in Patients with Stable Angina: Can CT Compete with Angiography?

Prospective comparison of integrated on-site CT-fractional flow reserve and static CT perfusion with coronary CT angiography for detection of flow-limiting coronary stenosis

FFR CT and Static Computed Tomography Myocardial Perfusion Imaging for Therapeutic Decision-making and Prognosis in Patients with Coronary Artery Disease.

FFRCT and Static Computed Tomography Myocardial Perfusion Imaging for Therapeutic Decision-making and Prognosis in Patients With Coronary Artery Disease

Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow

Noninvasive assessment of coronary artery flow reserve by transthoracic Doppler echocardiography in patients with coronary artery disease

The Coronary Flow Reserve in Patients with Coronary Slow Flow and Diagnostic Value of Myocardial Work Indices for Coronary Slow Flow

Non-invasive CT-derived fractional flow reserve and static rest and stress CT myocardial perfusion imaging for detection of haemodynamically significant coronary stenosis

Enhanced Diagnostic Utility Achieved By Myocardial Blood Analysis: A Meta-Analysis Of Noninvasive Cardiac Imaging In The Detection Of Functional Coronary Artery Disease

A Novel Method for Calculating CTFFR Based on the Flow Ratio Between Stenotic Coronary and Healthy Coronary.

Three-dimensional Modeling and Numerical Analysis of Fractional Flow Reserve in Human Coronary Arteries

Diagnostic performance of CT-derived resting distal to aortic pressure ratio (resting Pd/Pa) vs. CT-derived fractional flow reserve (CT-FFR) in coronary lesion severity assessment

The Evaluation of Combined Fractional Flow Reserve and Dynamic SPECT in Chronic Total Occlusion

Non-invasive Analysis Coronary Artery Flow Velocity of Slow Coronary Flow Phenomenon